Differential Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine, L-3H-Methionine, and 3H-Deoxyglucose in Brain Abscesses

The amino acid O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) has been shown to be a useful tracer for brain tumor imaging. Experimental studies demonstrated no uptake of (18)F-FET in inflammatory cells but increased uptake has been reported in single cases of human brain abscesses. To explore this...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of nuclear medicine (1978) Vol. 48; no. 12; pp. 2056 - 2062
Main Authors Salber, Dagmar, Stoffels, Gabriele, Pauleit, Dirk, Oros-Peusquens, Anna-Maria, Shah, Nadim Jon, Klauth, Peter, Hamacher, Kurt, Coenen, Heinz Hubert, Langen, Karl-Josef
Format Journal Article
LanguageEnglish
Published United States Soc Nuclear Med 01.12.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The amino acid O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) has been shown to be a useful tracer for brain tumor imaging. Experimental studies demonstrated no uptake of (18)F-FET in inflammatory cells but increased uptake has been reported in single cases of human brain abscesses. To explore this inconsistency, we investigated the uptake of (18)F-FET in comparison with that of L-[methyl-(3)H]methionine ((3)H-MET) and D-(3)H-deoxyglucose ((3)H-DG) in brain and calf abscesses in rats. Abscesses were induced in the brain (n = 9) and calf (n = 5) of Fisher CDF rats after inoculation of Staphylococcus aureus. Five days later, (18)F-FET and (3)H-MET (n = 10) or (18)F-FET and (3)H-DG (n = 4) were injected intravenously. One hour after injection the rats were sacrificed, and the brain or calf muscle was investigated using dual-tracer autoradiography. Lesion-to-background ratios (L/B) and standardized uptake values (SUVs) were calculated. The autoradiograms were compared with histology and immunostaining for glial fibrillary acidic protein (GFAP), CD68 for macrophages, and CD11b for microglia. (18)F-FET uptake in the area of macrophage infiltration and activated microglia at the rim of the brain abscesses was low (L/B, 1.5 +/- 0.4). In contrast, high uptake was observed for (3)H-MET as well as for (3)H-DG (L/B, 4.1 +/- 1.1 for (3)H-MET vs. 3.1 +/- 1.5 for (3)H-DG; P < 0.01 vs. (18)F-FET). Results for calf abscesses were similar. In the vicinity of the brain abscesses, slightly increased uptake was noted for (18)F-FET (L/B, 1.8 +/- 0.3) and (3)H-MET (L/B, 1.8 +/- 0.4), whereas (3)H-DG distribution was normal (L/B, 1.2 +/- 0.2). Anti-GFAP immunofluorescence showed a diffuse astrocytosis in those areas. Our results demonstrate that there is no accumulation of (18)F-FET in macrophages and activated microglia in experimental brain abscesses, whereas (3)H-MET and (3)H-DG exhibit high uptake in these cells. Thus, the specificity of (18)F-FET for gliomas may be superior to that (3)H-MET and (3)H-DG. Increased (18)F-FET uptake in human brain abscesses appears to be related to reactive astrocytosis.
AbstractList The amino acid O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) has been shown to be a useful tracer for brain tumor imaging. Experimental studies demonstrated no uptake of (18)F-FET in inflammatory cells but increased uptake has been reported in single cases of human brain abscesses. To explore this inconsistency, we investigated the uptake of (18)F-FET in comparison with that of L-[methyl-(3)H]methionine ((3)H-MET) and D-(3)H-deoxyglucose ((3)H-DG) in brain and calf abscesses in rats. Abscesses were induced in the brain (n = 9) and calf (n = 5) of Fisher CDF rats after inoculation of Staphylococcus aureus. Five days later, (18)F-FET and (3)H-MET (n = 10) or (18)F-FET and (3)H-DG (n = 4) were injected intravenously. One hour after injection the rats were sacrificed, and the brain or calf muscle was investigated using dual-tracer autoradiography. Lesion-to-background ratios (L/B) and standardized uptake values (SUVs) were calculated. The autoradiograms were compared with histology and immunostaining for glial fibrillary acidic protein (GFAP), CD68 for macrophages, and CD11b for microglia. (18)F-FET uptake in the area of macrophage infiltration and activated microglia at the rim of the brain abscesses was low (L/B, 1.5 +/- 0.4). In contrast, high uptake was observed for (3)H-MET as well as for (3)H-DG (L/B, 4.1 +/- 1.1 for (3)H-MET vs. 3.1 +/- 1.5 for (3)H-DG; P < 0.01 vs. (18)F-FET). Results for calf abscesses were similar. In the vicinity of the brain abscesses, slightly increased uptake was noted for (18)F-FET (L/B, 1.8 +/- 0.3) and (3)H-MET (L/B, 1.8 +/- 0.4), whereas (3)H-DG distribution was normal (L/B, 1.2 +/- 0.2). Anti-GFAP immunofluorescence showed a diffuse astrocytosis in those areas. Our results demonstrate that there is no accumulation of (18)F-FET in macrophages and activated microglia in experimental brain abscesses, whereas (3)H-MET and (3)H-DG exhibit high uptake in these cells. Thus, the specificity of (18)F-FET for gliomas may be superior to that (3)H-MET and (3)H-DG. Increased (18)F-FET uptake in human brain abscesses appears to be related to reactive astrocytosis.
UNLABELLEDThe amino acid O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) has been shown to be a useful tracer for brain tumor imaging. Experimental studies demonstrated no uptake of (18)F-FET in inflammatory cells but increased uptake has been reported in single cases of human brain abscesses. To explore this inconsistency, we investigated the uptake of (18)F-FET in comparison with that of L-[methyl-(3)H]methionine ((3)H-MET) and D-(3)H-deoxyglucose ((3)H-DG) in brain and calf abscesses in rats.METHODSAbscesses were induced in the brain (n = 9) and calf (n = 5) of Fisher CDF rats after inoculation of Staphylococcus aureus. Five days later, (18)F-FET and (3)H-MET (n = 10) or (18)F-FET and (3)H-DG (n = 4) were injected intravenously. One hour after injection the rats were sacrificed, and the brain or calf muscle was investigated using dual-tracer autoradiography. Lesion-to-background ratios (L/B) and standardized uptake values (SUVs) were calculated. The autoradiograms were compared with histology and immunostaining for glial fibrillary acidic protein (GFAP), CD68 for macrophages, and CD11b for microglia.RESULTS(18)F-FET uptake in the area of macrophage infiltration and activated microglia at the rim of the brain abscesses was low (L/B, 1.5 +/- 0.4). In contrast, high uptake was observed for (3)H-MET as well as for (3)H-DG (L/B, 4.1 +/- 1.1 for (3)H-MET vs. 3.1 +/- 1.5 for (3)H-DG; P < 0.01 vs. (18)F-FET). Results for calf abscesses were similar. In the vicinity of the brain abscesses, slightly increased uptake was noted for (18)F-FET (L/B, 1.8 +/- 0.3) and (3)H-MET (L/B, 1.8 +/- 0.4), whereas (3)H-DG distribution was normal (L/B, 1.2 +/- 0.2). Anti-GFAP immunofluorescence showed a diffuse astrocytosis in those areas.CONCLUSIONOur results demonstrate that there is no accumulation of (18)F-FET in macrophages and activated microglia in experimental brain abscesses, whereas (3)H-MET and (3)H-DG exhibit high uptake in these cells. Thus, the specificity of (18)F-FET for gliomas may be superior to that (3)H-MET and (3)H-DG. Increased (18)F-FET uptake in human brain abscesses appears to be related to reactive astrocytosis.
Author Hamacher, Kurt
Salber, Dagmar
Klauth, Peter
Pauleit, Dirk
Coenen, Heinz Hubert
Langen, Karl-Josef
Shah, Nadim Jon
Oros-Peusquens, Anna-Maria
Stoffels, Gabriele
Author_xml – sequence: 1
  fullname: Salber, Dagmar
– sequence: 2
  fullname: Stoffels, Gabriele
– sequence: 3
  fullname: Pauleit, Dirk
– sequence: 4
  fullname: Oros-Peusquens, Anna-Maria
– sequence: 5
  fullname: Shah, Nadim Jon
– sequence: 6
  fullname: Klauth, Peter
– sequence: 7
  fullname: Hamacher, Kurt
– sequence: 8
  fullname: Coenen, Heinz Hubert
– sequence: 9
  fullname: Langen, Karl-Josef
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18006612$$D View this record in MEDLINE/PubMed
BookMark eNo9kE1vGyEQhlGUKnHS_IBcqj1VqRRchjUsPuajbiq5yiU5I5YdYtw1uOBV639f3LVyGebjeQd4L8hpiAEJuQY25XPZfF2HYYPdFFgzZTMpQZyQCYhaUCFlc0omDCRQIZg4Jxc5rxljUil1Rs5BlVQCn5Dto3cOE4adN331ut2ZX1hFVz3TG05BLeiiH2KKuFvt-y90SV_2KWYf8LZa0vqJ_iwDH8P_hgldVVqPGP_u3_rBxoyVD9V9MiXetdlizpg_kg_O9BmvjucleV18e3l4osvn7z8e7pbUciUF7cAAs5wpdEwaB7xmTWuhA2ihtdbMFBqmpBPKCtYKruZOKikFWm4RXFdfks_j3m2KvwfMO73x5Ql9bwLGIWs5Z7zhTBQQRtCWn-WETm-T35i018D0wWY92lzKRo82F82n4_KhPYzeFUdfC3AzAiv_tvrjE-ow2B5NOtDrsJkpDVyX62X9D2kgiFM
CitedBy_id crossref_primary_10_1097_RLU_0000000000003741
crossref_primary_10_3389_fonc_2021_721821
crossref_primary_10_1007_s00330_021_07732_0
crossref_primary_10_2310_7290_2012_00027
crossref_primary_10_3171_2012_12_FOCUS12336
crossref_primary_10_2967_jnumed_112_103069
crossref_primary_10_2967_jnumed_114_148734
crossref_primary_10_1053_j_semnuclmed_2008_02_005
crossref_primary_10_1053_j_semnuclmed_2012_06_001
crossref_primary_10_1038_nrneurol_2017_44
crossref_primary_10_2310_7290_2014_00015
crossref_primary_10_2967_jnumed_116_176610
crossref_primary_10_1093_noajnl_vdz010
crossref_primary_10_2967_jnumed_122_264812
crossref_primary_10_1093_neuonc_nov148
crossref_primary_10_1007_s40336_013_0017_z
crossref_primary_10_22328_2079_5343_2022_13_2_85_93
crossref_primary_10_1097_RLU_0b013e3182443c92
crossref_primary_10_2967_jnumed_122_264859
crossref_primary_10_1016_S1634_7072_19_43056_0
crossref_primary_10_2967_jnumed_111_090597
crossref_primary_10_1016_j_pharmthera_2021_107964
crossref_primary_10_1016_j_nucmedbio_2017_07_005
crossref_primary_10_1093_neuonc_noaa239
crossref_primary_10_3390_molecules25061471
crossref_primary_10_1007_s00062_022_01139_0
crossref_primary_10_1016_j_nucmedbio_2020_02_006
crossref_primary_10_1097_RLU_0000000000001873
crossref_primary_10_1016_j_cpet_2012_09_005
crossref_primary_10_1021_acs_jmedchem_0c01053
crossref_primary_10_2967_jnumed_111_096859
crossref_primary_10_1093_neuros_nyy461
crossref_primary_10_1136_bmjopen_2022_062555
crossref_primary_10_2967_jnumed_107_049213
crossref_primary_10_1097_RLU_0000000000001516
crossref_primary_10_20862_0042_4676_2020_101_4_221_234
crossref_primary_10_1038_onc_2011_169
crossref_primary_10_1093_neuonc_noab013
crossref_primary_10_2967_jnumed_122_264803
crossref_primary_10_2967_jnumed_115_158998
crossref_primary_10_1093_neuonc_not059
crossref_primary_10_1016_j_nucmedbio_2009_05_005
crossref_primary_10_1016_j_ymeth_2017_05_019
crossref_primary_10_3390_molecules27092792
crossref_primary_10_1097_RLU_0000000000003324
crossref_primary_10_2967_jnumed_113_122960
crossref_primary_10_1371_journal_pone_0230618
crossref_primary_10_3390_cancers14040879
crossref_primary_10_1007_s10555_008_9154_7
crossref_primary_10_2967_jnumed_112_103325
crossref_primary_10_1007_s13139_024_00847_4
crossref_primary_10_1055_a_1335_4844
crossref_primary_10_1134_S1068162009030042
crossref_primary_10_1039_B916722F
crossref_primary_10_1097_RLU_0b013e3181f4a18b
crossref_primary_10_3413_Nukmed_0650_14_03
crossref_primary_10_1016_j_nucmedbio_2019_12_002
crossref_primary_10_2967_jnumed_119_225680
crossref_primary_10_1007_s00259_012_2109_9
crossref_primary_10_54548_njps_v36i2_1
crossref_primary_10_1097_RLU_0000000000002197
crossref_primary_10_2967_jnumed_108_050880
crossref_primary_10_2174_1874471012666190111111046
crossref_primary_10_1016_j_cpet_2020_12_004
crossref_primary_10_1186_1748_717X_3_44
crossref_primary_10_1016_j_nucmedbio_2013_05_001
crossref_primary_10_14791_btrt_2018_6_e13
crossref_primary_10_3389_fneur_2016_00120
crossref_primary_10_1007_s11307_017_1137_z
crossref_primary_10_1016_j_cpet_2019_08_002
crossref_primary_10_2967_jnumed_109_071423
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.2967/jnumed.107.046615
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-5667
EndPage 2062
ExternalDocumentID 10_2967_jnumed_107_046615
18006612
jnm48_12_2056
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
1AW
29L
2WC
3V.
53G
55
5RE
7RV
7X7
88E
88I
8AF
8AO
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
8WZ
A6W
ABFLS
ABSGY
ABUWG
ACGOD
ACIWK
ACPRK
ADACO
ADBIT
ADDZX
AENEX
AFFNX
AFKRA
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
ARAPS
AZQEC
BBAFP
BBNVY
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EX3
F5P
FH7
FYUFA
GJ
GNUQQ
H13
HCIFZ
I-F
IL9
INIJC
KQ8
L7B
LK8
M1P
M2P
M2Q
M7P
OK1
P2P
P62
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
R0Z
RHF
RHI
RNS
RWL
S0X
SJN
SV3
TAE
TSM
VH1
WH7
WOQ
WOW
X
X7M
ZA5
---
-~X
.55
.GJ
3O-
41~
ABEFU
ABLYK
ABSQV
AFOSN
AI.
CCPQU
CGR
CUY
CVF
EBD
ECM
EIF
EMOBN
F9R
HMCUK
I4R
J5H
N4W
NAPCQ
NPM
TR2
TUS
UKHRP
W8F
YHG
YQJ
ZGI
ZXP
AAYXX
ALIPV
CITATION
7X8
ID FETCH-LOGICAL-c2865-d1a10c208ef06af12307bc1d11b1bcca48ea086f58c50b5289f68665ec2ce1fd3
ISSN 0161-5505
IngestDate Fri Aug 16 07:19:59 EDT 2024
Fri Aug 23 01:47:54 EDT 2024
Thu May 23 23:11:30 EDT 2024
Mon Jan 18 12:03:10 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2865-d1a10c208ef06af12307bc1d11b1bcca48ea086f58c50b5289f68665ec2ce1fd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://jnm.snmjournals.org/content/jnumed/48/12/2056.full.pdf
PMID 18006612
PQID 69027205
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_69027205
crossref_primary_10_2967_jnumed_107_046615
pubmed_primary_18006612
highwire_nuclearmed_jnm48_12_2056
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20071201
2007-Dec
2007-12-01
PublicationDateYYYYMMDD 2007-12-01
PublicationDate_xml – month: 12
  year: 2007
  text: 20071201
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of nuclear medicine (1978)
PublicationTitleAlternate J Nucl Med
PublicationYear 2007
Publisher Soc Nuclear Med
Publisher_xml – name: Soc Nuclear Med
SSID ssj0006888
Score 1.9002357
Snippet The amino acid O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) has been shown to be a useful tracer for brain tumor imaging. Experimental studies demonstrated...
UNLABELLEDThe amino acid O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) has been shown to be a useful tracer for brain tumor imaging. Experimental studies...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 2056
SubjectTerms Animals
Blood-Brain Barrier
Brain Abscess - metabolism
Deoxyglucose - pharmacokinetics
Fluorine Radioisotopes
Male
Methionine - pharmacokinetics
Radiopharmaceuticals - pharmacokinetics
Rats
Rats, Inbred F344
Tritium
Tyrosine - analogs & derivatives
Tyrosine - pharmacokinetics
Title Differential Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine, L-3H-Methionine, and 3H-Deoxyglucose in Brain Abscesses
URI http://jnm.snmjournals.org/cgi/content/abstract/48/12/2056
https://www.ncbi.nlm.nih.gov/pubmed/18006612
https://search.proquest.com/docview/69027205
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6TUK8IO4rlxIkHrjMI05zcR6BrVRobSfaSnuLbMdBHW1S9SIxfjK_gnPiJE07kAYvUeumjpPvy_E5x-ccE_LK44FINItp7KqQuoknqVChoNLGGjiuBNTRod_r-92x--XCu2g0ftWiltYreax-_jGv5H9QhTbAFbNk_wHZqlNogM-ALxwBYTjeCOOTYneTFbq9x_OV-J57AAYU1EaHMt6hnek6W2Qa0JiCzU_P6OgKpsWJcWOe0XaX9uDH3Cery0BOaDzR2Y-rMpp9kgIDBPpFQMZgqfFlXaPd5JZNTVCIwo0oqjX7vBAU2JA1j8NQYF0tE1D_bSaq6ODhKoPbmRpXvZALTH3frHCtp3qSTxggpKvsogHcDD3X6yXGg5t9ldNU0J4wwdMbf0awExsyzNS7fjHU3lZ-F-imFO0pM3OV4tqjoJAGdXnu8jpvnbp0tk0R891pwwl9XLi-TOHv8THDqpYu6C1e_VxAfj7LecQ46mlFx1sFvHcm1irc8TKduTxiToQD2CMHThB66Cjgnc-V1uDzfI_U6i7NCjyO7P21cWGl22IQ2-pUWeL67-ZSrjaN7pI7BTOsD4a890hDp_fJrV7BjgdkXuewZThsZYk1oK-vMfhNjb9H1g57jyzgrrXDXWuSWjl3rYq7D8m4czr61KXFLiBUYdY0jZlgtnJsrhPbFwnDzAWpWMyYZFJhUX4twC5PPK48W3oODxMfizhq5SjNkrj9iOynWaoPidWO44RjJrktwTBmPmfaszVre6HiMkxkk7wtH2Y0N8VeIjCSEYTIgABfg8iA0CQvy8cdFe8WnrCFdZO8KHGIQGzjWpxIdbZeRn5oYwQE9PLYwLO5YIHskxv0_5Tc3rxCz8j-arHWz0FJXskW2QsuglbOsRY5-HjaP__6Gy6uuZQ
link.rule.ids 315,786,790,27957,27958,31755,33409,33780
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+Uptake+of+O-%282-18F-Fluoroethyl%29-L-Tyrosine%2C+L-3H-Methionine%2C+and+3H-Deoxyglucose+in+Brain+Abscesses&rft.jtitle=The+Journal+of+nuclear+medicine+%281978%29&rft.au=Salber%2C+Dagmar&rft.au=Stoffels%2C+Gabriele&rft.au=Pauleit%2C+Dirk&rft.au=Oros-Peusquens%2C+Anna-Maria&rft.date=2007-12-01&rft.pub=Soc+Nuclear+Med&rft.issn=0161-5505&rft.eissn=1535-5667&rft.volume=48&rft.issue=12&rft.spage=2056&rft_id=info:doi/10.2967%2Fjnumed.107.046615&rft_id=info%3Apmid%2F18006612&rft.externalDBID=n%2Fa&rft.externalDocID=jnm48_12_2056
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon